bpc tb ghk cu BPC-157, TB500, KPV, GHK-Cu (Recovery) GLOW: GHK-Cu, TB-500, and BPC-157

Long-term human safety data does not exist, which is the main caution

Originally characterized by the Sikiric group at the University of Zagreb School of Medicine, BPC-157 is unusual among peptides for its reported oral activity attributed to its origin in gastric juice, which suggests evolutionary adaptation to the digestive environment

Its one of the oldest synthetic pharmaceutical compounds in existence, and it has nothing to do with neurotrophic signaling or synaptogenesis

Each injection is administered subcutaneously once per week

The bad news is that many of those options carry the same risks that ultimately brought Amino Asylum down